Clinical Trial: The Use of CT Perfusion to Determine the Normalization Window Period in the Treatment of Advanced Primary Lung Adenocarcinoma With Endostar

Study Status: Not yet recruiting
Recruit Status: Unknown status
Study Type: Interventional

Official Title: The Use of CT Perfusion to Determine the Normalization Window Period in the Treatment of Advanced Primary Lung Adenocarcinoma With Endostar

Brief Summary: To evaluate the change of blood perfusion before/after the use of Endostar, discuss the time sequence of Endostar TM in treating advanced lung adenocarcinoma in normalization window period.

Detailed Summary:
Sponsor: Simcere Pharmaceutical Co., Ltd

Current Primary Outcome: the change of blood perfusion before/after the use of Endostar [ Time Frame: per 3 weeks ]

Original Primary Outcome: Same as current

Current Secondary Outcome:

  • tumor to progress [ Time Frame: 6 months ]
    tumor to progress
  • clinical benefit rate [ Time Frame: per 6 weeks ]
  • Adverse Drug Reaction [ Time Frame: per 1 day ]
    NCI-CTCAE V3.0


Original Secondary Outcome: Same as current

Information By: Simcere Pharmaceutical Co., Ltd

Dates:
Date Received: March 21, 2012
Date Started: March 2012
Date Completion: July 2013
Last Updated: March 23, 2012
Last Verified: March 2012